News
SOPH
7.86
+5.29%
0.40
Weekly Report: what happened at SOPH last week (1102-1106)?
Weekly Report · 3d ago
Insider Returns Down To US$40k As SOPHiA GENETICS' Stock Dips 11%
Simply Wall St · 11/05 10:50
SOPHiA Genetics GAAP EPS of -$0.24, revenue of $24.3M
Seeking Alpha · 11/03 20:59
SOPHiA (SOPH) Q3 2026 Earnings Call Transcript
The Motley Fool · 11/03 20:38
SOPHiA GENETICS SA Reports Third Quarter 2026 Financial Results
NASDAQ · 11/03 17:12
Sophia Genetics Q3 2026 Earnings Call Transcript
Benzinga · 11/03 14:03
SOPHiA GENETICS Reports 25% Third-Quarter Revenue Growth
TipRanks · 11/03 13:36
Sophia Genetics reports Q3 EPS (24c), consensus (20c)
TipRanks · 11/03 12:07
Sophia Genetics backs FY26 revenue view $94M-$96M, consensus $95.23M
TipRanks · 11/03 12:06
SOPHiA GENETICS SA (SOPH) Reports Q3 Loss, Beats Revenue Estimates
NASDAQ · 11/03 12:00
Sophia Genetics Raises FY2026 Sales Guidance from $94.000M-$96.000M to $96.000M vs $95.252M Est
Benzinga · 11/03 11:47
Sophia Genetics Q3 EPS $(0.24) Misses $(0.18) Estimate, Sales $24.267M Beat $24.035M Estimate
Benzinga · 11/03 11:46
SOPHiA GENETICS Reports Third Quarter 2026 Results
PR Newswire · 11/03 11:45
Analysts’ Top Healthcare Picks: Incyte (INCY), BrightSpring Health Services, Inc. (BTSG)
TipRanks · 11/02 14:11
Weekly Report: what happened at SOPH last week (1026-1030)?
Weekly Report · 11/02 09:13
Weekly Report: what happened at SOPH last week (1019-1023)?
Weekly Report · 10/26 09:12
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2026 on November 3, 2026
PR Newswire · 10/20 12:00
Weekly Report: what happened at SOPH last week (1012-1016)?
Weekly Report · 10/19 09:12
Weekly Report: what happened at SOPH last week (1005-1009)?
Weekly Report · 10/12 09:13
Myriad Genetics, SOPHiA GENETICS Partner With AstraZeneca On Prostate Cancer PrGIS
NASDAQ · 10/08 14:50
More
Webull provides a variety of real-time SOPH stock news. You can receive the latest news about Sophia Genetics Sa through multiple platforms. This information may help you make smarter investment decisions.
About SOPH
SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.